2024-11-13 |
2024-11-13 |
B
Purchase
|
Conroy Kevin T
President and CEO
Executive Director
|
19,500
+1.8%
51.35
USD 1,001,325
|
19,500
+1.8%
|
51.35
|
USD 1,001,325
|
|
2024-10-09 |
2024-10-08 |
PS
Planned sale
|
Baranick Brian
EVP, GM, Precision Oncology
Officer
|
929
-6.8%
70.00
USD 65,030
|
929
-6.8%
|
70.00
|
USD 65,030
|
|
2024-09-19 |
2024-09-18 |
PS
Planned sale
|
Baranick Brian
EVP, GM, Precision Oncology
Officer
|
929
-6.4%
70.00
USD 65,030
|
929
-6.4%
|
70.00
|
USD 65,030
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Conroy Kevin T
President and CEO
Executive Director
|
1,155
-0.1%
60.15
USD 69,473
|
1,155
-0.1%
|
60.15
|
USD 69,473
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Conroy Kevin T
President and CEO
Executive Director
|
1,155
-0.1%
60.15
USD 69,473
|
1,155
-0.1%
|
60.15
|
USD 69,473
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Baranick Brian
EVP, GM., Precision Oncology
Officer
|
110
-0.8%
60.15
USD 6,617
|
110
-0.8%
|
60.15
|
USD 6,617
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Baranick Brian
EVP, GM., Precision Oncology
Officer
|
110
-0.8%
60.15
USD 6,617
|
110
-0.8%
|
60.15
|
USD 6,617
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
102
-0.7%
60.15
USD 6,135
|
102
-0.7%
|
60.15
|
USD 6,135
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
102
-0.7%
60.15
USD 6,135
|
102
-0.7%
|
60.15
|
USD 6,135
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Elliott Jeffrey Thomas
Chief Financial Officer
Officer
|
136
-1.1%
60.15
USD 8,180
|
136
-1.1%
|
60.15
|
USD 8,180
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Elliott Jeffrey Thomas
Chief Financial Officer
Officer
|
136
-1.1%
60.15
USD 8,180
|
136
-1.1%
|
60.15
|
USD 8,180
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
102
-0.1%
60.15
USD 6,135
|
102
-0.1%
|
60.15
|
USD 6,135
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
COWARD D SCOTT
Non-Executive Director
|
67
-0.1%
60.15
USD 4,030
|
67
-0.1%
|
60.15
|
USD 4,030
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Herriott James
SVP, General Counsel & Sec
Officer
|
30
-0.3%
60.15
USD 1,805
|
30
-0.3%
|
60.15
|
USD 1,805
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Cunningham Everett
Chief Commercial Officer
Officer
|
136
-0.3%
60.15
USD 8,180
|
136
-0.3%
|
60.15
|
USD 8,180
|
|
2024-04-03 |
2024-04-02 |
PS
Planned sale
|
Baranick Brian
EVP, GM., Precision Oncology
Officer
|
924
-6.6%
79.43
USD 73,393
|
924
-6.6%
|
79.43
|
USD 73,393
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
2,000
-2.7%
70.00
USD 140,000
|
2,000
-2.7%
|
70.00
|
USD 140,000
|
|
2024-04-01 |
2024-03-28 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
2,000
-2.6%
70.00
USD 140,000
|
2,000
-2.6%
|
70.00
|
USD 140,000
|
|
2024-03-04 |
2024-03-01 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
2,154
-13.1%
59.32
USD 127,775
|
2,154
-13.1%
|
59.32
|
USD 127,775
|
|
2024-03-04 |
2024-03-01 |
PS
Planned sale
|
Herriott James
General Counsel
Officer
|
862
-8.6%
59.32
USD 51,134
|
862
-8.6%
|
59.32
|
USD 51,134
|
|
2024-03-04 |
2024-03-01 |
PS
Planned sale
|
Conroy Kevin T
President and CEO
Executive Director
|
8,271
-0.6%
59.32
USD 490,636
|
8,271
-0.6%
|
59.32
|
USD 490,636
|
|
2024-03-04 |
2024-03-01 |
PS
Planned sale
|
Elliott Jeffrey Thomas
Chief Financial Officer
Officer
|
2,412
-18.1%
59.32
USD 143,080
|
2,412
-18.1%
|
59.32
|
USD 143,080
|
|
2024-03-04 |
2024-03-01 |
PS
Planned sale
|
Cunningham Everett
Chief Commercial Officer
Officer
|
2,412
-5.0%
59.32
USD 143,080
|
2,412
-5.0%
|
59.32
|
USD 143,080
|
|
2024-03-04 |
2024-03-01 |
PS
Planned sale
|
Doyle James Edward
Non-Executive Director
|
2,000
-3.8%
57.50
USD 115,000
|
2,000
-3.8%
|
57.50
|
USD 115,000
|
|
2024-03-04 |
2024-03-01 |
PS
Planned sale
|
Baranick Brian
Gen. Mgr., Precision Oncology
Officer
|
2,323
-14.1%
59.32
USD 137,800
|
2,323
-14.1%
|
59.32
|
USD 137,800
|
|
2024-03-04 |
2024-03-01 |
PS
Planned sale
|
LEVANGIE DANIEL J
Non-Executive Director
|
5,000
-17.9%
57.50
USD 287,500
|
5,000
-17.9%
|
57.50
|
USD 287,500
|
|
2024-03-04 |
2024-03-01 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
1,724
-2.2%
59.32
USD 102,268
|
1,724
-2.2%
|
59.32
|
USD 102,268
|
|
2024-02-28 |
2024-02-27 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
1,880
-2.5%
56.89
USD 106,953
|
1,880
-2.5%
|
56.89
|
USD 106,953
|
|
2024-02-28 |
2024-02-27 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
1,879
-13.8%
56.89
USD 106,896
|
1,879
-13.8%
|
56.89
|
USD 106,896
|
|
2024-02-28 |
2024-02-27 |
PS
Planned sale
|
Baranick Brian
Gen. Mgr., Precision Oncology
Officer
|
2,027
-14.8%
56.89
USD 115,316
|
2,027
-14.8%
|
56.89
|
USD 115,316
|
|
2024-02-28 |
2024-02-27 |
PS
Planned sale
|
Herriott James
General Counsel
Officer
|
784
-8.8%
56.89
USD 44,602
|
784
-8.8%
|
56.89
|
USD 44,602
|
|
2024-02-28 |
2024-02-27 |
PS
Planned sale
|
Conroy Kevin T
President and CEO
Executive Director
|
6,263
-0.5%
56.89
USD 356,302
|
6,263
-0.5%
|
56.89
|
USD 356,302
|
|
2024-02-28 |
2024-02-27 |
PS
Planned sale
|
Cunningham Everett
Chief Commercial Officer
Officer
|
3,648
-7.8%
56.89
USD 207,535
|
3,648
-7.8%
|
56.89
|
USD 207,535
|
|
2024-02-28 |
2024-02-27 |
PS
Planned sale
|
Elliott Jeffrey Thomas
Chief Financial Officer
Officer
|
2,710
-25.2%
56.89
USD 154,172
|
2,710
-25.2%
|
56.89
|
USD 154,172
|
|
2024-02-26 |
2024-02-23 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
1,021
-1.4%
59.72
USD 60,974
|
1,021
-1.4%
|
59.72
|
USD 60,974
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
1,013
-1.4%
59.78
USD 60,557
|
1,013
-1.4%
|
59.78
|
USD 60,557
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
Elliott Jeffrey Thomas
Chief Financial Officer
Officer
|
1,351
-21.1%
59.78
USD 80,763
|
1,351
-21.1%
|
59.78
|
USD 80,763
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
COWARD D SCOTT
Non-Executive Director
|
663
-1.5%
59.78
USD 39,634
|
663
-1.5%
|
59.78
|
USD 39,634
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
Conroy Kevin T
President and CEO
Executive Director
|
11,565
-0.9%
59.78
USD 691,356
|
11,565
-0.9%
|
59.78
|
USD 691,356
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
1,013
-9.5%
59.78
USD 60,557
|
1,013
-9.5%
|
59.78
|
USD 60,557
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
Cunningham Everett
Chief Commercial Officer
Officer
|
1,350
-3.3%
59.78
USD 80,703
|
1,350
-3.3%
|
59.78
|
USD 80,703
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
Herriott James
General Counsel
Officer
|
291
-3.9%
59.78
USD 17,396
|
291
-3.9%
|
59.78
|
USD 17,396
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
Baranick Brian
Gen. Mgr., Precision Oncology
Officer
|
1,093
-10.1%
59.78
USD 65,340
|
1,093
-10.1%
|
59.78
|
USD 65,340
|
|
2024-02-22 |
2024-02-21 |
PS
Planned sale
|
Conroy Kevin T
President and CEO
Executive Director
|
4,975
-0.4%
61.50
USD 305,963
|
4,975
-0.4%
|
61.50
|
USD 305,963
|
|
2024-02-22 |
2024-02-21 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
1,078
-11.1%
61.50
USD 66,297
|
1,078
-11.1%
|
61.50
|
USD 66,297
|
|
2024-02-22 |
2024-02-21 |
PS
Planned sale
|
Baranick Brian
Gen. Mgr., Precision Oncology
Officer
|
895
-9.2%
61.50
USD 55,043
|
895
-9.2%
|
61.50
|
USD 55,043
|
|
2024-02-22 |
2024-02-21 |
PS
Planned sale
|
COWARD D SCOTT
Non-Executive Director
|
706
-1.6%
61.50
USD 43,419
|
706
-1.6%
|
61.50
|
USD 43,419
|
|
2024-02-22 |
2024-02-21 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
1,079
-1.5%
61.50
USD 66,359
|
1,079
-1.5%
|
61.50
|
USD 66,359
|
|
2024-02-22 |
2024-02-21 |
PS
Planned sale
|
Herriott James
General Counsel
Officer
|
415
-5.6%
61.50
USD 25,523
|
415
-5.6%
|
61.50
|
USD 25,523
|
|
2024-02-22 |
2024-02-21 |
PS
Planned sale
|
Elliott Jeffrey Thomas
Chief Financial Officer
Officer
|
1,493
-28.7%
61.50
USD 91,820
|
1,493
-28.7%
|
61.50
|
USD 91,820
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
965
-1.4%
61.43
USD 59,280
|
965
-1.4%
|
61.43
|
USD 59,280
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
COWARD D SCOTT
Non-Executive Director
|
1,376
-3.2%
61.43
USD 84,528
|
1,376
-3.2%
|
61.43
|
USD 84,528
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
Herriott James
General Counsel
Officer
|
421
-6.1%
61.43
USD 25,862
|
421
-6.1%
|
61.43
|
USD 25,862
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
966
-11.4%
61.43
USD 59,341
|
966
-11.4%
|
61.43
|
USD 59,341
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
Elliott Jeffrey Thomas
Chief Financial Officer
Officer
|
1,888
-47.5%
61.43
USD 115,980
|
1,888
-47.5%
|
61.43
|
USD 115,980
|
|
2024-02-16 |
2024-02-15 |
PS
Planned sale
|
Conroy Kevin T
President and CEO
Executive Director
|
14,791
-1.2%
61.43
USD 908,611
|
14,791
-1.2%
|
61.43
|
USD 908,611
|
|
2024-01-04 |
2024-01-02 |
PS
Planned sale
|
Baranick Brian
Gen. Mgr., Precision Oncology
Officer
|
879
-9.9%
73.50
USD 64,607
|
879
-9.9%
|
73.50
|
USD 64,607
|
|
2024-01-04 |
2024-01-02 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
2,000
-2.8%
73.50
USD 147,000
|
2,000
-2.8%
|
73.50
|
USD 147,000
|
|
2023-12-18 |
2023-12-14 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
2,000
-2.7%
70.00
USD 140,000
|
2,000
-2.7%
|
70.00
|
USD 140,000
|
|
2023-10-13 |
2023-10-12 |
PS
Planned sale
|
Cunningham Everett
Chief Commercial Officer
Officer
|
13,007
-25.5%
66.49
USD 864,835
|
13,007
-25.5%
|
66.49
|
USD 864,835
|
|
2023-09-06 |
2023-09-01 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
4,500
-5.6%
84.36
USD 379,620
|
4,500
-5.6%
|
84.36
|
USD 379,620
|
|
2023-08-23 |
2023-08-21 |
PS
Planned sale
|
Elliott Jeffrey Thomas
Chief Financial Officer
Officer
|
30,210
-100.0%
82.92
USD 2,505,013
|
30,210
-100.0%
|
82.92
|
USD 2,505,013
|
|
2023-08-08 |
2023-08-07 |
PS
Planned sale
|
Baranick Brian
Gen. Mgr., Precision Oncology
Officer
|
1,350
-13.2%
85.04
USD 114,804
|
1,350
-13.2%
|
85.04
|
USD 114,804
|
|
2023-07-28 |
2023-07-27 |
PS
Planned sale
|
Doyle James Edward
Non-Executive Director
|
2,000
-3.7%
97.42
USD 194,840
|
2,000
-3.7%
|
97.42
|
USD 194,840
|
|
2023-07-21 |
2023-07-19 |
PS
Planned sale
|
Herriott James
General Counsel
Officer
|
1,300
-17.9%
100.00
USD 130,000
|
1,300
-17.9%
|
100.00
|
USD 130,000
|
|
2023-06-12 |
2023-06-09 |
PS
Planned sale
|
Doyle James Edward
Non-Executive Director
|
1,402
-2.5%
90.51
USD 126,895
|
1,402
-2.5%
|
90.51
|
USD 126,895
|
|
2023-06-12 |
2023-06-09 |
PS
Planned sale
|
Zanotti Katherine S
Non-Executive Director
|
3,027
-4.5%
90.51
USD 273,974
|
3,027
-4.5%
|
90.51
|
USD 273,974
|
|
2023-06-12 |
2023-06-08 |
PS
Planned sale
|
Herriott James
General Counsel
Officer
|
1,300
-15.2%
90.00
USD 117,000
|
1,300
-15.2%
|
90.00
|
USD 117,000
|
|
2023-05-31 |
2023-05-26 |
PS
Planned sale
|
Doyle James Edward
Non-Executive Director
|
2,000
-3.7%
80.62
USD 161,240
|
2,000
-3.7%
|
80.62
|
USD 161,240
|
|
2023-05-12 |
2023-05-10 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
5,000
-43.8%
80.00
USD 400,000
|
5,000
-43.8%
|
80.00
|
USD 400,000
|
|
2023-05-12 |
2023-05-10 |
PS
Planned sale
|
Herriott James
General Counsel
Officer
|
1,300
-13.2%
79.85
USD 103,805
|
1,300
-13.2%
|
79.85
|
USD 103,805
|
|
2023-05-12 |
2023-05-10 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
6,087
-7.0%
80.00
USD 486,960
|
6,087
-7.0%
|
80.00
|
USD 486,960
|
|
2023-05-03 |
2023-05-01 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
1,000
-1.1%
63.78
USD 63,780
|
1,000
-1.1%
|
63.78
|
USD 63,780
|
|
2023-04-05 |
2023-04-03 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
1,000
-1.1%
67.19
USD 67,190
|
1,000
-1.1%
|
67.19
|
USD 67,190
|
|
2023-03-07 |
2023-03-03 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
5,000
-30.4%
65.00
USD 325,000
|
5,000
-30.4%
|
65.00
|
USD 325,000
|
|